Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Standards of Care II01:19

Standards of Care II

1.1K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing Early Onset GBS Neonatal Sepsis - Are Second Line Intrapartum Antibiotics Equivalent to No Antibiotics at All?

Journal of the American Board of Family Medicine : JABFM·2026
Same author

Gastric Cancer: Rapid Evidence Review.

American family physician·2025
Same author

Antibiotic Treatment for Uncomplicated Acute Appendicitis in Children.

American family physician·2025
Same author

A "no-biopsy" approach to diagnosing celiac disease.

The Journal of family practice·2022
Same author

Impact of the STAR*D trial from the perspective of the payer.

Psychiatric services (Washington, D.C.)·2009

Related Experiment Video

Updated: May 4, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

CMS coverage for obesity management.

Patricia Marincic1, Carrie Gray

  • 1Patricia Marincic is an associate professor and director of the didactic program in dietetics at Auburn University in Auburn, Ala. Carrie Gray is an assistant professor and associate clinical coordinator of the PA program at St. Catherine University in St. Paul, Minn. The authors have indicated no relationships to disclose relating to the content of this article.

JAAPA : Official Journal of the American Academy of Physician Assistants
|December 24, 2013
PubMed
Summary

Intensive behavioral management for obesity is now covered by Medicare and Medicaid Services. This review covers primary care strategies for effective obesity management.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

2.0K

Related Experiment Videos

Last Updated: May 4, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

2.0K

Area of Science:

  • Obesity Management
  • Primary Care Medicine
  • Behavioral Health

Background:

  • Obesity is a complex chronic disease with significant public health implications.
  • Effective management strategies are crucial for improving patient outcomes.
  • Recent policy changes by the Centers for Medicare and Medicaid Services (CMS) impact obesity treatment coverage.

Purpose of the Study:

  • To review current, evidence-based strategies for intensive behavioral management of obesity.
  • To outline practical approaches for implementing these strategies within primary care settings.
  • To inform healthcare providers about CMS coverage for obesity management services.

Main Methods:

  • Literature review of studies on intensive behavioral interventions for obesity.
  • Analysis of primary care models for delivering obesity management.
  • Examination of CMS guidelines and coverage policies.

Main Results:

  • Intensive behavioral interventions, including counseling and lifestyle modification programs, show significant efficacy.
  • Primary care settings are well-positioned to integrate obesity management services.
  • CMS coverage expansion facilitates patient access to these critical interventions.

Conclusions:

  • Primary care physicians can effectively manage obesity using intensive behavioral strategies.
  • Enhanced access to care through CMS coverage supports comprehensive obesity treatment.
  • Integrating behavioral management into primary care is key to combating the obesity epidemic.